Clinical trialNCT07103746RecruitingPhase 2Interventional

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment30Autoimmune Disorders

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Julie Paik, M.D., M.H.S.
Johns Hopkins Hospital: Division of Rheumatology
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Alabama at Birmingham School of Medicine: Division of Clinical Immunology & Rheumatology
Birmingham, Alabama, United States
James Andrews, MD
Not, yet, recruiting
Emory University School of Medicine: Division of Rheumatology
Atlanta, Georgia, United States
Prateek Gandiga, MD
Not, yet, recruiting
University of Chicago, Department of Medicine: Rheumatology
Chicago, Illinois, United States
Iazsmin Ventura, MD
Not, yet, recruiting
Johns Hopkins Hospital: Division of Rheumatology
Baltimore, Maryland, United States
Julie Paik, MD
Recruiting
Mayo Clinic: Division of Rheumatology
Rochester, Minnesota, United States
Elie Naddaf, MD
Not, yet, recruiting
Northwell Health: Division of Rheumatology and Allergy-Clinical Immunology
Great Neck, New York, United States
Galina Marder, MD
Not, yet, recruiting
University of Pittsburgh Medical Center: Division of Rheumatology and Clinical Immunology
Pittsburgh, Pennsylvania, United States
Chester Oddis, MD
Not, yet, recruiting
University of Texas - Houston
Houston, Texas, United States
Eleni Tiniakou, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 26 Feb 2026
Primary completion: 31 Aug 2028
Completion: 31 Aug 2029
Last update posted: 16 Jun 2026
Registered enrollment: 30
Registry id: NCT07103746

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.